Ignite Creation Date:
2025-12-25 @ 12:03 AM
Ignite Modification Date:
2026-02-19 @ 1:08 AM
Study NCT ID:
NCT02654158
Status:
COMPLETED
Last Update Posted:
2017-05-22
First Post:
2016-01-11
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Phase IV Trial,The Efficacy and Safety Study of Fuganlin Oral Liquid in Children With Acute Upper Respiratory Infection
Sponsor:
Guangzhou Yipinhong Pharmaceutical CO.,LTD
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
2013Pro234.EKZY
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None